Safety study of investigational Drug in schizophrenia
This study is completed in the United States, in Romania, in Russia, .... It is testing investigational Drug for schizophrenia.
In United States
Compare studies and check their requirements with the research team.
This study is completed in the United States, in Romania, in Russia, .... It is testing investigational Drug for schizophrenia.
In United StatesThis study is completed in the United States. It focuses on Addiction.
In United StatesThis study is completed in the United States. It is testing relationship of Psychosocial Function With Mood Symptoms for Bipolarity.
In United StatesThis study is completed in the United States, in Austria, in India, .... It is testing safety and Efficacy of Injectable Risperidone for Bipolarity.
In United StatesThis study is completed in the United States, in France, in the United Kingdom, .... It is testing safety and Efficacy of Pimavanserin for Schizophrenia.
In United StatesThis study is completed in the United States. It is testing Safety and Efficacy of SP-624 for depression.
In United StatesThis study is completed in the United States. It is testing ziprasidone for Schizophrenia.
In United StatesThis study is completed in the United States, in France, in Canada, .... It is testing pimavanserin for Schizophrenia.
In United StatesThis study is completed in the United States. It is testing Safety, PK, and Exploratory Efficacy of SP-624 for schizophrenia.
In United StatesThis study is completed in the United States. It is testing Safety, Tolerability and Pharmacokientics of RO5545965 for schizophrenia.
In United StatesThis study is completed in the United States. It is testing Single Doses Of PF-05180999 for Schizophrenia.
In United StatesThis study is completed in the United States. It is testing tolerability and Efficacy of Cannabidiol on Motor Symptoms for Schizophrenia.
In United StatesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.